Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Blueprint Genetics | RCV000788950 | SCV000928251 | pathogenic | not provided | 2019-02-25 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001226542 | SCV001398861 | pathogenic | Leukocyte adhesion deficiency 1 | 2023-09-01 | criteria provided, single submitter | clinical testing | ClinVar contains an entry for this variant (Variation ID: 636972). This premature translational stop signal has been observed in individuals with leukocyte adhesion deficiency (PMID: 16595236, 21103413, 30412664). This variant is present in population databases (rs148877937, gnomAD 0.01%). This sequence change creates a premature translational stop signal (p.Arg188*) in the ITGB2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ITGB2 are known to be pathogenic (PMID: 22134107, 25703682). For these reasons, this variant has been classified as Pathogenic. |
Laboratorio de Genetica e Diagnostico Molecular, |
RCV001226542 | SCV002512756 | pathogenic | Leukocyte adhesion deficiency 1 | 2022-02-08 | criteria provided, single submitter | clinical testing | ACMG classification criteria: PVS1 very strong, PS4 strong, PM2 moderate, PM3 strong |